Mouse APOBEC3 expression in NIH 3T3 cells mediates hypermutation of AKV murine leukemia virus. [PDF]
Virology, 2018 Boi S +4 more
europepmc +1 more source
The Hsp90β Isoform: An Attractive Target for Drug Development
Medicinal Research Reviews, Volume 45, Issue 5, Page 1452-1465, September 2025.ABSTRACT The beta isoform of 90 kDa heat shock protein (Hsp90β) plays a critical role in maintaining cellular proteostasis by assisting in the folding and refolding of proteins, which is essential for both normal cellular function and stress response.
Subhabrata Chaudhury +2 more
wiley +1 more source
SARS-CoV-2 Spike S2 Refolding: Structural Insights and Inhibition Strategies Against Emerging Variants. [PDF]
MedComm (2020)MedComm, Volume 6, Issue 8, August 2025.
Xu C, Xie W, Long X.
europepmc +2 more sources
A MAJOR GENETIC LOCUS AFFECTING RESISTANCE TO INFECTION WITH MURINE LEUKEMIA VIRUSES [PDF]
, 1973 Wallace P. Rowe +2 more
openalex +1 more source
Persistent Infection of a Rat Kidney Cell Line with Rauscher Murine Leukemia Virus
Journal of Bacteriology, 1966 H. Duc-Nguyen, E. Rosenblum, R. Zeigel
semanticscholar +1 more source
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
MedComm – Oncology, Volume 4, Issue 3, September 2025.Senescent tumor cells in TME exhibit dual roles. “Angels” secrete SASPs/DAMPs to boost immunological clearance and antitumor immunity via MHC‐I upregulation; “Demons” produce tumor‐promoting SASPs recruiting MDSCs to drive malignancy. ABSTRACT Cellular senescence, a state of irreversible cell cycle arrest accompanied by a senescence‐associated ...
Jingrui Yan +5 more
wiley +1 more source
Non-templated addition and template switching by Moloney murine leukemia virus (MMLV)-based reverse transcriptases co-occur and compete with each other. [PDF]
J Biol Chem, 2019 Wulf MG +7 more
europepmc +1 more source
Host-Gene Control of C-Type RNA Tumor Virus: Inheritance of the Group-Specific Antigen of Murine Leukemia Virus [PDF]
, 1971 Benjamin A. Taylor +2 more
openalex +1 more source
MedComm – Oncology, Volume 4, Issue 3, September 2025.Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun +10 more
wiley +1 more source